Gina Mazzariello Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity

Gina Mazzariello is Chief Legal Officer of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 148,141 shares of AMLX, which is worth approximately $1.88 Million. The most recent transaction as insider was on Sep 30, 2025, when has been sold 8,828 shares (Common Stock) at a price of $14.58 per share, resulting in proceeds of $128,712. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 148K

0% 3M change

3.76% 12M change

Total Value Held $1.88 Million

Gina Mazzariello Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2025	SELL Open market or private sale	$128,712 $14.58 p/Share	8,828 Reduced 5.62%	148,141 Common Stock
Aug 13 2025	SELL Open market or private sale	$125,100 $8.34 p/Share	15,000 Reduced 8.72%	156,969 Common Stock
Aug 12 2025	SELL Open market or private sale	$121,050 $8.07 p/Share	15,000 Reduced 8.02%	171,969 Common Stock
May 22 2025	SELL Bona fide gift	-	1,000 Reduced 0.53%	186,969 Common Stock
Mar 31 2025	SELL Open market or private sale	$31,988 $3.48 p/Share	9,192 Reduced 4.66%	187,969 Common Stock
Mar 06 2025	BUY Grant, award, or other acquisition	-	63,851 Added 24.46%	197,161 Common Stock
Mar 03 2025	SELL Open market or private sale	$5,026 $3.12 p/Share	1,611 Reduced 1.19%	133,310 Common Stock

Feb 24 2025	SELL Open market or private sale	$13,132 $3.15 p/Share	4,169 Reduced 3.0%	134,921 Common Stock
Feb 03 2025	SELL Open market or private sale	$12,836 $3.49 p/Share	3,678 Reduced 2.58%	139,090 Common Stock
Sep 30 2024	SELL Open market or private sale	$27,868 $3.2 p/Share	8,709 Reduced 5.75%	142,768 Common Stock
May 15 2024	SELL Open market or private sale	$19,655 $1.88 p/Share	10,455 Reduced 6.46%	151,477 Common Stock
Apr 16 2024	BUY Grant, award, or other acquisition	-	80,560 Added 33.22%	161,932 Common Stock
Mar 05 2024	SELL Open market or private sale	$28,844 $18.73 p/Share	1,540 Reduced 1.86%	81,372 Common Stock
Feb 26 2024	BUY Grant, award, or other acquisition	-	36,667 Added 30.66%	82,912 Common Stock
Feb 23 2024	SELL Open market or private sale	$53,240 $18.76 p/Share	2,838 Reduced 5.78%	46,245 Common Stock
Aug 15 2023	SELL Open market or private sale	$128,704 $20.88 p/Share	6,164 Reduced 11.16%	49,083 Common Stock
May 17 2023	SELL Bona fide gift	-	500 Reduced 0.9%	55,247 Common Stock
Mar 16 2023	BUY Grant, award, or other acquisition	-	18,333 Added 24.75%	55,747 Common Stock
Feb 24 2023	SELL Open market or private sale	$123,681 $34.49 p/Share	3,586 Reduced 8.75%	37,414 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	-	41,000 Added 50.0%	41,000 Common Stock

Gina Mazzariello

Chief Legal Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMLX shares.

Notify only if

Value

Insider Trading

Get notified when an Amylyx Pharmaceuticals, Inc. insider buys or sells AMLX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Amylyx Pharmaceuticals, Inc.

Track Activities on AMLX

Account